These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 24983365)
1. Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases. Joosse SA; Müller V; Steinbach B; Pantel K; Schwarzenbach H Br J Cancer; 2014 Aug; 111(5):909-17. PubMed ID: 24983365 [TBL] [Abstract][Full Text] [Related]
2. Melanoma-associated antigen genes: a new trend to predict the prognosis of breast cancer patients. Abd-Elsalam EA; Ismaeil NA Med Oncol; 2014 Nov; 31(11):285. PubMed ID: 25316266 [TBL] [Abstract][Full Text] [Related]
3. Tumor suppressor let-7a inhibits breast cancer cell proliferation, migration and invasion by targeting MAGE-A1. Mi Y; Liu F; Liang X; Liu S; Huang X; Sang M; Geng C Neoplasma; 2019 Jan; 66(1):54-62. PubMed ID: 30509089 [TBL] [Abstract][Full Text] [Related]
4. Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Vatolin S; Abdullaev Z; Pack SD; Flanagan PT; Custer M; Loukinov DI; Pugacheva E; Hong JA; Morse H; Schrump DS; Risinger JI; Barrett JC; Lobanenkov VV Cancer Res; 2005 Sep; 65(17):7751-62. PubMed ID: 16140943 [TBL] [Abstract][Full Text] [Related]
5. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein. Schwarzenbach H; Eichelser C; Steinbach B; Tadewaldt J; Pantel K; Lobanenkov V; Loukinov D BMC Cancer; 2014 Nov; 14():796. PubMed ID: 25363021 [TBL] [Abstract][Full Text] [Related]
6. Expression of BORIS in melanoma: lack of association with MAGE-A1 activation. Kholmanskikh O; Loriot A; Brasseur F; De Plaen E; De Smet C Int J Cancer; 2008 Feb; 122(4):777-84. PubMed ID: 17957795 [TBL] [Abstract][Full Text] [Related]
7. Molecular strategy for detecting metastatic cancers with use of multiple tumor-specific MAGE-A genes. Miyashiro I; Kuo C; Huynh K; Iida A; Morton D; Bilchik A; Giuliano A; Hoon DS Clin Chem; 2001 Mar; 47(3):505-12. PubMed ID: 11238304 [TBL] [Abstract][Full Text] [Related]
8. MAGE A1-A6 RT-PCR and MAGE A3 and p16 methylation analysis in induced sputum from patients with lung cancer and non-malignant lung diseases. Shin KC; Lee KH; Lee CH; Shin IH; Suh HS; Jeon CH Oncol Rep; 2012 Apr; 27(4):911-6. PubMed ID: 22134685 [TBL] [Abstract][Full Text] [Related]
9. Clinical Significance of let-7a-5p and miR-21-5p in Patients with Breast Cancer. Chen C; Liu X; Chen C; Chen Q; Dong Y; Hou B Ann Clin Lab Sci; 2019 May; 49(3):302-308. PubMed ID: 31308028 [TBL] [Abstract][Full Text] [Related]
10. Effects of long non-coding RNA HOST2 on cell migration and invasion by regulating MicroRNA let-7b in breast cancer. Lu PW; Li L; Wang F; Gu YT J Cell Biochem; 2018 Jun; 119(6):4570-4580. PubMed ID: 29236319 [TBL] [Abstract][Full Text] [Related]
11. [Detection rate of MAGE-A1-A6 mRNA in the peripheral blood of cancer patients]. Novikov DV; Belova TV; Pegov RG; Aliasova AA; Morozova PN; Kniazev DI; Kalugin AV; Kontorshchikova KN; Baryshnikov AIu; Novikov VV Klin Lab Diagn; 2009 Apr; (4):25-7. PubMed ID: 19514330 [TBL] [Abstract][Full Text] [Related]
12. Plasma miR-21, miR-155, miR-10b, and Let-7a as the potential biomarkers for the monitoring of breast cancer patients. Khalighfard S; Alizadeh AM; Irani S; Omranipour R Sci Rep; 2018 Dec; 8(1):17981. PubMed ID: 30568292 [TBL] [Abstract][Full Text] [Related]
13. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients. Qattan A; Intabli H; Alkhayal W; Eltabache C; Tweigieri T; Amer SB BMC Cancer; 2017 Nov; 17(1):799. PubMed ID: 29183284 [TBL] [Abstract][Full Text] [Related]
14. Targeted expression of suicide gene by tissue-specific promoter and microRNA regulation for cancer gene therapy. Danda R; Krishnan G; Ganapathy K; Krishnan UM; Vikas K; Elchuri S; Chatterjee N; Krishnakumar S PLoS One; 2013; 8(12):e83398. PubMed ID: 24391761 [TBL] [Abstract][Full Text] [Related]
15. MAGE-A gene expression pattern in primary breast cancer. Otte M; Zafrakas M; Riethdorf L; Pichlmeier U; Löning T; Jänicke F; Pantel K Cancer Res; 2001 Sep; 61(18):6682-7. PubMed ID: 11559535 [TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients. Eichelser C; Stückrath I; Müller V; Milde-Langosch K; Wikman H; Pantel K; Schwarzenbach H Oncotarget; 2014 Oct; 5(20):9650-63. PubMed ID: 25333260 [TBL] [Abstract][Full Text] [Related]
17. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Wischnewski F; Pantel K; Schwarzenbach H Mol Cancer Res; 2006 May; 4(5):339-49. PubMed ID: 16687489 [TBL] [Abstract][Full Text] [Related]
18. Co-expression of cancer testis antigens and topoisomerase 2-alpha in triple negative breast carcinomas. Mrklić I; Spagnoli GC; Juretić A; Pogorelić Z; Tomić S Acta Histochem; 2014 Jun; 116(5):740-6. PubMed ID: 24560456 [TBL] [Abstract][Full Text] [Related]
19. Detection of occult metastatic breast cancer cells in blood by a multimolecular marker assay: correlation with clinical stage of disease. Taback B; Chan AD; Kuo CT; Bostick PJ; Wang HJ; Giuliano AE; Hoon DS Cancer Res; 2001 Dec; 61(24):8845-50. PubMed ID: 11751407 [TBL] [Abstract][Full Text] [Related]
20. MAGE-A gene expression in peripheral blood serves as a poor prognostic marker for patients with lung cancer. Gu L; Sang M; Yin D; Liu F; Wu Y; Liu S; Huang W; Shan B Thorac Cancer; 2018 Apr; 9(4):431-438. PubMed ID: 29430849 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]